z-logo
open-access-imgOpen Access
SAT-LB074 Efficacy and Safety of Once-weekly Somapacitan in Adult Growth Hormone Deficiency (AGHD) Confirmed in a 53‑week Real 1 Trial Extension
Author(s) -
Gudmundur Johannsson,
Murray B. Gordon,
Michael Højby Rasmussen,
Ida Holme Håkonsson,
Claus Sværke,
Shigeyuki Tahara,
Koji Takano,
Beverly M. K. Biller
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sat-lb074
Subject(s) - lean body mass , placebo , medicine , adipose tissue , lipid profile , body mass index , growth hormone , endocrinology , hormone , body weight , cholesterol , pathology , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here